Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

NCT07074353 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: NALIRI
RADIATION: LCRT
DRUG: FOLFOX

Sponsor

Zhejiang Cancer Hospital